TBPL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary <1E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.589500E-02
Normal-vs-Stage2
<1E-12
Normal-vs-Stage3
4.699600E-02
Normal-vs-Stage4
1.514410E-01
Stage1-vs-Stage2
6.727400E-01
Stage1-vs-Stage3
4.211000E-01
Stage1-vs-Stage4
6.874200E-01
Stage2-vs-Stage3
5.204200E-01
Stage2-vs-Stage4
4.193800E-01
Stage3-vs-Stage4
2.217400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.62436730732907E-12
Normal-vs-AfricanAmerican
6.060300E-02
Normal-vs-Asian
2.197200E-03
Caucasian-vs-AfricanAmerican
3.732800E-01
Caucasian-vs-Asian
4.650800E-01
AfricanAmerican-vs-Asian
2.109400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.63580260448271E-12
Normal-vs-Female
<1E-12
Male-vs-Female
9.655400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.714100E-02
Normal-vs-Age(41-60Yrs)
2.17109999999243E-05
Normal-vs-Age(61-80Yrs)
<1E-12
Normal-vs-Age(81-100Yrs)
4.550500E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.845600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.483600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.141600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.096100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.070400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.348800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.56930074174988E-11
Normal-vs-Daily Drinker
1.32150000053954E-07
Normal-vs-Weekly Drinker
2.370200E-04
Normal-vs-Occasional Drinker
3.504000E-01
Normal-vs-Social Drinker
3.51410000000163E-05
Non Drinker-vs-Daily Drinker
8.774800E-01
Non Drinker-vs-Weekly Drinker
7.575200E-01
Non Drinker-vs-Occasional Drinker
8.426200E-02
Non Drinker-vs-Social Drinker
5.407400E-01
Daily Drinker-vs-Weekly Drinker
7.065200E-01
Daily Drinker-vs-Occasional Drinker
8.019700E-02
Daily Drinker-vs-Social Drinker
5.183200E-01
Weekly Drinker-vs-Occasional Drinker
1.409000E-01
Weekly Drinker-vs-Social Drinker
8.397800E-01
Occasional Drinker-vs-Social Drinker
1.578800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.423400E-01
Normal-vs-Grade 2
8.838200E-01
Normal-vs-Grade 3
9.406000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.641000E-01
Grade 1-vs-Grade 3
1.486830E-01
Grade 1-vs-Grade 4
8.423400E-01
Grade 2-vs-Grade 3
2.964000E-01
Grade 2-vs-Grade 4
8.838200E-01
Grade 3-vs-Grade 4
9.406000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.59552404411079E-14
Normal-vs-NonDiabetic
1.62470037423645E-12
Diabetic-vs-NonDiabetic
4.115700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.09539999965303E-07
Normal-vs-NoPancreatitis
1.62447832963153E-12
Pancreatitis-vs-NoPancreatitis
3.467600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.55529955370559E-10
Normal-vs-N1
<1E-12
N0-vs-N1
4.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.669500E-02
Normal-vs-TP53-NonMutant
3.779800E-01
TP53-Mutant-vs-TP53-NonMutant
5.829600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
